As of Apr 24
| -0.13 / -2.47%|
The 4 analysts offering 12-month price forecasts for CytRx Corp have a median target of 10.00, with a high estimate of 12.00 and a low estimate of 8.00. The median estimate represents a +94.93% increase from the last price of 5.13.
The current consensus among 4 polled investment analysts is to Buy stock in CytRx Corp. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.